Hematoporphyrin Photodynamic Therapy for Esophageal Cancer

PHASE4Not yet recruitingINTERVENTIONAL

Enrollment

198

Participants

Timeline

Start Date

September 18, 2024

Primary Completion Date

September 30, 2027

Study Completion Date

December 1, 2030

Conditions

Esophageal CancerPhotodynamic Therapy

Interventions

PROCEDURE

photodynamic therapy

Receive an intravenous infusion of hematoporphyrin injection

Trial Locations (1)

Endoscopic Department of Sun Yat-Sen University Cancer Center, Guangzhou

All Listed Sponsors

lead

Sun Yat-sen University

OTHER

NCT06437288 - Hematoporphyrin Photodynamic Therapy for Esophageal Cancer | Biotech Hunter | Biotech Hunter